Physician profile
Anil Kumar
NPI 1922092543
$1,443.61
in general payments reported to CMS, 2019-2025
19 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $299 · 2021: $110 · 2022: $259 · 2023: $85.40 · 2024: $161 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.00 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $311.82 | 2019-2025 | Aveir |
| Astellas Pharma US INC | $287.99 | 2020-2021 | |
| Medtronic Vascular, INC. | $183.63 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $89.64 | 2021-2025 | |
| Pfizer INC. | $74.54 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $70.35 | 2022 | |
| Irhythm Technologies, INC. | $70.26 | 2019 | |
| Stimwave Technologies Incorporated | $68.49 | 2022 | |
| Novo Nordisk INC | $43.86 | 2024 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $41.95 | 2023-2024 | Eliquis, Camzyos |
| Cvrx, INC. | $41.33 | 2024 | Barostim Neo System |
| Vital Connect, INC | $40.18 | 2023-2024 | Vitalpatch Rtm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.28 | 2025 | Jardiance |
| Amarin Pharma, INC. | $18.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.93 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.31 | 2024 | Repatha |
| Edwards Lifesciences Corporation | $15.79 | 2019 | |
| Baxter Healthcare | $15.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $14.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.